Although the effects of these DAO and DAOA nucleotide variations on their mRNA and protein expression in schizophrenia is not yet studied, these genes still remain as candidate genes for schizophrenia because of their role in the glutamatergic signaling. The gene discussed is DAO; the disease is schizophrenia.